Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
International Journal of Stroke : Official Journal of the International Stroke Society|April 6, 2019
Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selectionPeter Ringleb, Martin Bendszus, Erich Bluhmki, et al.
Circulation|August 28, 2014
ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-upPeter R Sinnaeve, Paul W Armstrong, Anthony H Gershlick, et al.
Stroke|October 18, 2008
Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST)Nils Wahlgren, Niaz Ahmed, Niclas Eriksson, et al.
Lancet (London, England)|March 16, 2004
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trialsWerner Hacke, Geoffrey Donnan, Cesare Fieschi, et al.
The New England Journal of Medicine|March 12, 2013
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarctionPaul W Armstrong, Anthony H Gershlick, Patrick Goldstein, et al.
Stroke|August 11, 2016
Effects of Alteplase for Acute Stroke on the Distribution of Functional Outcomes: A Pooled Analysis of 9 TrialsKennedy R Lees, Jonathan Emberson, Lisa Blackwell, et al.
Lancet (London, England)|May 18, 2010
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsKennedy R Lees, Erich Bluhmki, Rüdiger von Kummer, et al.
Lancet (London, England)|August 10, 2014
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trialsJonathan Emberson, Kennedy R Lees, Patrick Lyden, et al.
The Lancet. Neurology|June 13, 2016
Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysisWilliam N Whiteley, Jonathan Emberson, Kennedy R Lees, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 25, 2017
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trialsWerner Hacke, Patrick Lyden, Jonathan Emberson, et al.
Pageof 6